help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gulati, R.
Right arrow Articles by Peluso, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gulati, R.
Right arrow Articles by Peluso, J. J.
Endocrinology Vol. 138, No. 5 1847-1856
Copyright © 1997 by The Endocrine Society


Articles

Opposing Actions of Hepatocyte Growth Factor and Basic Fibroblast Growth Factor on Cell Contact, Intracellular Free Calcium Levels, and Rat Ovarian Surface Epithelial Cell Viability

R. Gulati and J. J. Peluso

Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut 06030

Address all correspondence and requests for reprints to: John J. Peluso, Department of Obstetrics and Gynecology, University of Connecticut Health Center, Farmington, Connecticut 06030.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Previous studies demonstrated that cell-to-cell contact stimulates a tyrosine phosphorylation signal transduction pathway that prevents rat ovarian surface epithelial (ROSE) cells from undergoing apoptosis. Hepatocyte growth factor (HGF), also know as scatter factor (SF), is expressed by ovarian stromal and thecal cells and has been shown to reduce cell contact in nonovarian tissues. The present studies were designed to determine whether HGF/SF promotes ROSE cells to dissociate and subsequently become apoptotic. Because an increase in intracellular free calcium ([Ca2+]i) is often an early event in the apoptotic cascade, the effects of HGF/SF on [Ca2+]i levels were also assessed. ROSE cells were cultured in serum-free medium with HGF/SF, basic fibroblast growth factor (bFGF), thapsigargin, Bay K, actinomycin D, cycloheximide, and/or BAPTA depending on the experimental design. Cell contact was assayed by time-lapse photography; [Ca2+]i levels were measured with Fluo-3, and apoptosis was assessed by in situ DNA staining. HGF/SF decreased cell contact within 1 h, increased [Ca2+]i levels by 3 h, and induced apoptosis by 6 h of culture. bFGF inhibited these HGF/SF-induced responses. The increase in [Ca2+]i appears to represent a point in the apoptotic cascade that commits ROSE cells to die. This concept is based on the observations that: 1) in the presence of the calcium chelator BAPTA, HGF/SF decreased cell contact but did not increase [Ca2+]i or apoptosis; 2) bFGF blocked HGF/SF-induced increase in [Ca2+]i; 3) bFGF did not attenuate HGF/SF’s apoptotic action if exposed to cells after the increase in [Ca2+]i; and 4) RNA and protein synthesis were required for HGF/SF to increase [Ca2+]i, whereas the thapsigargin- and Bay K-induced increase in [Ca2+]i and apoptosis were independent of RNA/protein synthesis. These observations indicate that the components of the apoptotic cascade distal to the increase in [Ca2+]i are present within ROSE cells and are activated by a sustained elevation of [Ca2+]i.

The present studies also show that when ROSE cells establish contact with 3T3 cells that express N-cadherin, [Ca2+]i levels are maintained at low basal levels. In contrast, cell contact with 3T3 cells that do not express N-cadherin results in elevated [Ca2+]i levels. Similarly, a synthetic N-cadherin peptide, which inhibits homophilic N-cadherin binding, increases [Ca2+]i levels. Taken together, these data indicate that homophilic N-cadherin binding between adhering cells plays an important role in maintaining calcium homeostasis. Further, these data support the concept that HGF/SF’s ability to promote the dissociation of ROSE cells accounts in part for its ability to increase [Ca2+]i levels.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
SEVERAL different ovarian cell types, including granulosa cells (1) and surface epithelial cells (2, 3, 4), die by an apoptotic mechanism. To date, most research has focused on the hormonal factors that promote the survival of granulosa cells. In addition, cell-to-cell contact maintains the viability of both granulosa cells and rat ovarian surface epithelial (ROSE) cells through a hormone-independent mechanism (4, 5). Although the mechanism through which cell contact affects its antiapoptotic action has not been completely discerned, it is known that the adhesion molecule, N-cadherin, mediates this function (4). Homophilic binding of N-cadherin molecules of adjacent cells results in the activation (i.e. tyrosine phosphorylation) of the fibroblast growth factor (FGF) receptors (4). In this manner, cell contact mimics the anti-apoptotic action of basic FGF (bFGF) (4, 6).

Because cell contact is important in maintaining both granulosa cell and ROSE cell viability, factors that enhance cell contact would likely promote viability, whereas factors that disrupt cell contact would likely induce apoptosis. In nonovarian tissue, Hepatocyte growth factor (HGF), also know as scatter factor (SF) often reduces cell contact (7, 8). Interestingly, HGF/SF is expressed by ovarian stromal and thecal cells (9), and its expression stimulated by estrogen (10). Further, c-met, the receptor for HGF/SF, is expressed by ovarian surface epithelial cells (11, 12). In spite of the fact that both HGF/SF and its receptor are expressed within the ovary, a role for HGF/SF in regulating ovarian function has not been clearly identified. Based on these findings, it is proposed that HGF/SF promotes ROSE cells to dissociate and subsequently become apoptotic. The present studies were conducted with a ROSE cell line as described by Hoffman et al. (13). These cells were derived from continuous passage of primary rat ovarian surface epithelial cell cultures. Although spontaneously immortalized, they are not tumorigenic (13). Specific experiments were designed to assess the effects of HGF/SF on mitosis, cell contact, and apoptosis. Intracellular free calcium ([Ca2+]i) levels were also examined, because an increase in [Ca2+]i is often associated with apoptosis (14). Finally, the ability of bFGF to modulate HGF/SF’s effects was studied, because the effects of cell contact can be mimicked by bFGF (4).


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
ROSE cell culture
ROSE cells were generously provided by Dr. Robert Burghardt of Texas A & M University (College Station, TX) and cultured in DMEM/F-12 medium (Sigma Chemical Co., St. Louis, MO) that was supplemented with 5% FBS (13). All cultures were maintained in a 5% CO2/air atmosphere at 37 C. For experimental procedures, ROSE cells were plated in eight-chamber glass lab-tek slides (Nunc Inc., Naperville, IL) at 30,000 cells/400 µl. After 24 h of culture in serum-supplemented medium, the ROSE cells were approximately 40–60% confluent. The ROSE cells were then washed with serum-free DMEM/F-12 medium and cultured in serum-free DMEM/F-12 with the various treatments. The following reagents were used at the indicated concentrations: bFGF (4 ng/400 µl, R&D Systems, Minneapolis, MN), recombinant HGF/SF (4 ng/400 µl, Genentech Inc., San Francisco, CA), thapsigargin (Thap) (0.25 µM, Sigma Chemical Co.), Bay K (1 µM, Sigma Chemical Co.), cycloheximide (CHX) (11 µM, Sigma Chemical Co.), actinomycin D (Act D) (4 µM, Sigma Chemical Co.), and BAPTA (5 µM, Molecular Probes, Eugene, OR). In experiments involving BAPTA, cells were loaded with BAPTA-acetoxymethyl in serum-supplemented medium at 37 C for 45 min. The cell cultures were then washed with serum-free medium and treated according to the experimental design.

Determination of ROSE proliferation
ROSE cell proliferation was determined using an in situ cell counting procedure as previously described with the following modifications (5). Briefly, cells were plated in eight-chamber lab-tek slides at 30,000 cells/400 µl and cultured in serum-supplemented medium for 24 h. The ROSE cells were then washed and cultured in serum-free medium (control) supplemented with either HGF/SF or bFGF. After 0 or 24 h of serum-free culture, the cultures were stained with hydroethidine (Polysciences, Warrington, PA; 14 µg/ml in DMEM/F-12 for 30 min) and observed through an inverted microscope with an epifluorescence attachment (15). The number of ROSE cells in four different grids (160 µm2) within each lab-tek well were counted. The grids were located at quadrants formed at the intersection of the horizontal and vertical axis of each well. Cell proliferation was expressed as the number of cells/640 µm2. Each proliferation experiment was conducted in duplicate and repeated at least three times.

Identification of apoptotic nuclei
After 6, 8, and 24 h of incubation with various treatments, ROSE cells were assessed for apoptosis. The nuclear structure of ROSE cells was revealed by staining the DNA with hydroethidine for 30 min as previously described (15). For each treatment at least 200 cells were examined, and those cells that possessed condensed and fragmented nuclei were considered to be apoptotic (15). The percentage of apoptotic cells was then calculated. These experiments were conducted in duplicate and repeated at least three times.

Assessment of [Ca2+]i levels
After 24 h in serum-supplemented medium, ROSE cells were loaded with Fluo-3 (Molecular Probes) as previously described (15). Cells were incubated with Fluo-3 (Molecular Probes, Eugene, OR) for 45 min in a 5% CO2/air atmosphere at 37 C. The cells were then washed with serum-free DMEM/F-12 and observed at 1–4 h of culture to assess the relative change in [Ca2+]i.

The relative level of [Ca2+]i was estimated by examining cells in four preselected fields that were located in the center of each well. Phase and fluorescent images of each field were collected and analyzed using IP Gel Lab software (Signal Analytics Corp., Vienna, VA). The cell size (area) and mean fluorescent intensity (fluorescent intensity/pixel) of each cell was determined from the fluorescent images with the phase images used to verify the position of each cell. The background fluorescent intensity was also determined in five areas within each field. The mean background fluorescent intensity was then calculated for each treatment and subtracted from the mean fluorescent intensity of each cell, thereby yielding a specific measurement of Fluo-3 fluorescence. In each experiment, the specific Fluo-3 fluorescence (i.e. [Ca2+]i) for 50–100 cells/treatment was determined. Each experiment was repeated at least three times. As part of the Fluo-3 validation procedure, a standard curve was generated in which the relationship between known fluorescence of a standard fluorescent particle was plotted against the fluorescent intensity units obtained using IP Gel Lab software. Fluorescent standards were constructed by first determining the fluorescence of a known particle under maximum fluorescent illumination. The same particle was then exposed to decreasing fluorescent illumination by reducing the amount of electrical current to the fluorescent illuminator using a reostat and then capturing the fluorescent image. The mean fluorescent intensity units obtained from each captured image was plotted against the percentage of fluorescent illumination. This study demonstrated that over the range in which Fluo-3 measurements were made, the mean fluorescent intensity increased linearly with increasing fluorescence of the particle as described by the equation: y = -92.4 + 0.51 X (R2 = 0.92).

Cell contact assessed by time-lapse photography
After 24 h of incubation in serum-supplemented medium, ROSE cells were washed with serum-free medium and then either cultured in serum-free medium or BAPTA-supplemented medium in the presence or absence of HGF/SF. For these studies, the lab-tek slide was sealed with a mixture of vasoline and paraffin (20:1) (MicroVideo Instruments, Arrow, MA) to maintain the pH of the medium. The lab-tek slide was then placed in a 37 C-humidified plexiglass microscope culture chamber (Nikon Corp., Japan). A field with several ROSE cell aggregates was selected and observed under either phase or Hoffman optics. Sequential images were collected at 0.5-h intervals over a 4-h period.

To ensure an accurate assessment of cell contact, only ROSE cells with three or less cell contacts were examined. A cell contact was considered lost when the cells were completely detached. The number of initial cell contacts that remained intact at each time interval was then counted and a percentage calculated. Experiments were done on 6 separate days, and at least 50 cell contacts were examined.

Coculture with N-cadherin-expressing 3T3 cells
Vector control 3T3 cells and N-cadherin-expressing 3T3 cells have been previously described (16) and were generously provided by Dr. Patrick Doherty (Guy’s Hospital, University of London, London, UK). These cells were routinely cultured in DMEM medium that was supplemented with 10% FBS. These cultures were maintained in a 8% CO2/air atmosphere at 37 C. For experimental procedures, vector control 3T3 cells, N-cadherin-expressing 3T3 cells, and ROSE cells were cultured in eight-chamber glass lab-tek slides with serum-supplemented medium until confluency.

A separate population of ROSE cells was collected and loaded with Fluo-3 as previously described, except that the loading and subsequent washing was done in a test tube. The confluent ROSE cells, vector control 3T3 cells, and N-cadherin-expressing 3T3 cells were then washed with serum-free medium. The cocultures were established by adding 1 x 104 Fluo-3-loaded ROSE cells in 400 µl serum-free medium. Additionally, Fluo-3-loaded ROSE cells were plated in glass lab-tek wells without an established cell layer. The cocultures were incubated at 37 C in either 8% CO2 (3T3 cultures) or 5% CO2 (ROSE cell cultures). The cultures were observed after 4 h to assess the relative change in [Ca2+]i as previously described. Fluo-3-loaded ROSE cells were easily identified in the cocultures because they were in a higher focal plane than the other cells and fluoresced when observed under epifluorescent illumination. For those cells plated on a glass substrate without a cellular monolayer, [Ca2+]i levels were assayed for single cells and aggregated ROSE cells. The coculture experiments were conducted in duplicate on 3 different days.

To further investigate N-cadherin’s role in regulating [Ca2+]i levels, Fluo-3-loaded ROSE cells were plated on a ROSE cell monolayer in the presence or absence of synthetic N-cadherin peptide. The synthetic N-cadherin peptide was synthesized at the Peptide Synthesis Facility of Yale University and used at a concentration of 1 mg/ml. The sequence of this peptide, free-LRAHAVDVNG-amide, was derived from the extracellular domain of the avian N-cadherin molecule and has been shown to block the ability of cell contact to prevent apoptosis (5).

Statistical analysis
Experiments that assessed cell proliferation were evaluated using Student’s t tests. Changes in cell contact were analyzed by chi-square and linear regression analysis. Data from experiments that assessed apoptosis were analyzed by ANOVA after determining that the percentage values were normally distributed. The data were then analyzed by a Student-Newman-Keuls multiple range test where appropriate. Regardless of the statistical test, only P values < 0.05 were considered to be significant.

Experiments involving Fluo-3 fluorescence (i.e. [Ca2+]i) were conducted on at least 3 different days and analyzed by ANOVA as described above. In each of the experiments, the specific Fluo-3 fluorescence for each cell was normalized to a control in an individual study. Therefore, all values were reported as a fold increase in [Ca2+]i levels over control values. The values were presented as the means ± SEM. The graphic presentation of changes in [Ca2+]i levels are from a representative experiment, except for the HGF/SF time course experiment where the data were pooled.


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
HGF/SF did not alter the number of ROSE cells present after 24 h of culture in serum-free medium as compared with control cultures (118 ± 15/640 µm2 for HGF/SF vs. 175 ± 24/640 µm2 for controls; P > 0.05) but increased the percentage of apoptotic ROSE cells (Fig. 1Go). The increase in apoptotic nuclei was first detected 6 h after HGF/SF, with a maximum response observed at 24 h (Fig. 1Go). Although both Act D and CHX increased the percentage of apoptotic nuclei, HGF/SF’s apoptotic action was not observed in the presence of either Act D or CHX (Fig. 2Go). The Act D- and CHX-induced increase in apoptosis was expected, because RNA and protein synthesis are required for cell survival.



View larger version (44K):
[in this window]
[in a new window]
 
Figure 1. Effect of HGF/SF on percentage of ROSE cells undergoing apoptosis. ROSE cells were cultured for 6, 8, and 24 h in serum-free medium, stained with hydroethidine, and apoptotic nuclei identified as described in Materials and Methods. Values in this and subsequent graphs represent means ± SEM.

 


View larger version (33K):
[in this window]
[in a new window]
 
Figure 2. Effect of serum-free medium, Act D, and CHX on HGF/SF- (A), Thapsigargin- (B), and Bay K-induced (C) apoptosis. *, Indicates that a value is significantly different from control value in each pair (P < 0.05).

 
HGF/SF affected the distribution and level of [Ca2+]i. Before culture, [Ca2+]i was evenly distributed throughout the cell. This distribution pattern and relative level of [Ca2+]i was maintained in controls throughout the 4-h culture period (Fig. 3Go, A–C). Cell size (area) in control cultures also remained constant averaging 850 ± 12 µm2. In addition, 95 ± 1% of the cell contacts were maintained over the 4-h culture period (Fig. 4Go). HGF/SF increased [Ca2+]i levels by approximately 3-fold at 3 and 4 h (Fig. 3CGo). In some HGF/SF-treated cells [Ca2+]i was distributed in a punctate pattern within the perinuclear region of the cytoplasm (Fig. 3BGo). Cell area remained at control values for up to 2 h of culture with HGF/SF and then decreased by approximately 40% at 3 and 4 h post HGF/SF treatment (520 ± 30 µm2 for 3 h and 510 ± 20 for 4 h; P < 0.05 compared with 2 h HGF/SF treatment and 3 h and 4 h control values). However, cell contact progressively decreased in response to HGF/SF, with the first significant decrease observed after 1 h of culture (Fig. 4Go). This HGF/SF-induced decrease in cell contact was also observed in the presence of BAPTA (Fig. 4Go).



View larger version (52K):
[in this window]
[in a new window]
 
Figure 3. Effect of HGF/SF on temporal changes in [Ca2+]i levels. After 24 h of culture, ROSE cells were loaded with Fluo-3 and treated with either HGF/SF or serum-free medium (control). [Ca2+]i levels were monitored at hourly intervals. [Ca2+]i levels are evenly distributed throughout cell (A). This pattern and relative [Ca2+]i level was maintained in control cultures. Because there was no change in control treatment over the 4-h period, control values were pooled and shown as shaded horizontal bar (C). By 3 h after treatment, some of cells show a redistribution of calcium into a punctate pattern (B). Note that HGF/SF induced at 3-fold increase in [Ca2+]i levels at 3 and 4 h after treatment (C). Values shown in this and subsequent graphs involving [Ca2+]i have been normalized to a control and are expressed as mean fold increases ± SEM (C). *, Indicates that a value is significantly different from control and 1-h and 2-h treatment groups (P < 0.05). A and B, Shown at a final magnification of x250.

 


View larger version (57K):
[in this window]
[in a new window]
 
Figure 4. Effect of HGF/SF on temporal changes in cell-cell contact. After 24 h of culture, ROSE cells were treated with either serum-free (control) or BAPTA-supplemented media in presence or absence of HGF/SF. Cell contacts were then monitored at 0.5-h intervals. In control and BAPTA cultures the number of cell contacts did not significantly decrease over the 4-h period. HGF/SF induced a significant decrease in cell contact as can be seen by comparing 0 h control (A) with 2 h post HGF/SF (B). The first statistically significant decrease in cell-cell contact was observed after 1 h of treatment (C). Number of cell contacts continued to decline throughout the 4-h culture period. A similar HGF/SF-induced decrease in cell contact was observed in presence of BAPTA. Lines represent best fit as described by linear regression analysis. A and B, Shown at a final magnification of x225.

 
Because an elevation in [Ca2+]i levels precedes an increase in HGF/SF-induced apoptosis, it is possible that the increase in [Ca2+]i levels induced ROSE cell apoptosis. To test this hypothesis, Fluo-3-loaded ROSE cells were cultured in the presence or absence of HGF/SF and/or BAPTA. In this study, BAPTA attenuated the ability of HGF/SF to increase [Ca2+]i levels (Fig. 5AGo). Similarly, BAPTA blocked HGF/SF’s apoptotic effects (Fig. 5BGo).



View larger version (33K):
[in this window]
[in a new window]
 
Figure 5. Effect of HGF/SF and BAPTA on [Ca2+]i levels (A) and apoptosis (B). [Ca2+]i levels were assessed after 4 h of treatment, whereas apoptosis was evaluated after 24 h of culture. *, Indicates that a value is significantly different from other values (P < 0.05).

 
To investigate the relationship between cell contact and [Ca2+]i levels, Fluo-3 loaded ROSE cells were either cocultured with ROSE cells or plated on glass lab-tek slides. The Fluo-3-loaded ROSE cells that established cell contact with either the ROSE cell monolayer or another Fluo-3-loaded cell fluoresced at relatively low levels (i.e. basal [Ca2+]i levels). Those Fluo-3-loaded cells that only attached to the glass substrate and did not form a cell contact possessed [Ca2+]i levels that were three times greater than aggregated cells (Fig. 6AGo). Similar experiments were conducted in which Fluo-3-loaded ROSE cells were cocultured with either N-cadherin-expressing 3T3 cells or vector control 3T3 cells. Those ROSE cells that attached to the N-cadherin-expressing 3T3 cells had a relatively low level of Fluo-3 fluorescence; whereas attachment to the vector control 3T3 cells resulted in a 3-fold increase in Fluo-3 fluorescence (Fig. 6BGo). Likewise, Fluo-3-loaded ROSE cells that established cell contact in the presence of synthetic N-cadherin peptide had higher [Ca2+]i levels than controls (Fig. 6CGo).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 6. Effect of N-cadherin-mediated cell contact on [Ca2+]i levels in ROSE cells. A, Relative level of [Ca2+]i within individual Fluo-3-loaded ROSE cells that established contact with either ROSE cell monolayer, another Fluo-3-loaded ROSE cell (i.e. agg cells), or glass substrate (i.e. single cells). [Ca2+]i levels are shown in relationship to Fluo-3 fluorescence of cells that made contact with ROSE cell monolayer. B, [Ca2+]i levels associated with cell contact with either N-cadherin-expressing 3T3 or vector control 3T3 cells. [Ca2+]i levels are expressed relative to N-cadherin-expressing 3T3 cells. C, [Ca2+]i levels of Fluo-3-loaded ROSE cells that established contact with a ROSE cell monolayer in presence or absence of synthetic N-cadherin peptide. *, Indicates that a value is significantly different from other values (P < 0.05).

 
To determine whether HGF/SF’s ability to increase [Ca2+]i levels was dependent on de novo RNA synthesis, [Ca2+]i levels were measured in the presence or absence of Act D. HGF/SF increased [Ca2+]i by {approx}3-fold in the absence (Fig. 7AGo) but not in the presence of Act D (Fig. 7BGo). Bay K induced an increase in [Ca2+]i even in the presence of Act D (Fig. 7CGo).



View larger version (38K):
[in this window]
[in a new window]
 
Figure 7. Effect of Act D on HGF/SF- and Bay K -induced increase in [Ca2+]i. After loading with Fluo-3 and 4 h in serum-free culture, [Ca2+]i levels were measured. A and B, Effect of HGF/SF in absence or presence of Act D, respectively. C, Effect of Bay K in presence of Act D. *, indicates that a value is significantly different from control values (P < 0.05).

 
Although bFGF did not increase ROSE cell proliferation after 24 h in serum-free culture medium (209 ± 29 cells/640 µm2 for bFGF vs. 175 ± 24 cells/640 µm2 for controls, P > 0.05), it decreased ROSE cell apoptosis (Fig. 8Go). In addition, bFGF attenuated HGF/SF’s effects on apoptosis (Fig. 8Go), [Ca2+]i levels (Fig. 8Go), and cell contact (data not shown). However, bFGF only inhibited HGF/SF’s effect if it was added at the time of or 2 h after HGF/SF. If added 4 h after HGF/SF, bFGF did not prevent apoptosis (Fig. 9Go).



View larger version (36K):
[in this window]
[in a new window]
 
Figure 8. Effect of HGF/SF and bFGF on [Ca2+]i levels (A) and apoptosis (B). For [Ca2+]i measurements, Fluo-3-loaded cells were cultured for 4 h in serum-free medium. Apoptosis was assessed after 24 h of treatment. *, Indicates that a value is significantly different from all other values (P < 0.05). **, Indicates value is less than control value (P < 0.05).

 


View larger version (45K):
[in this window]
[in a new window]
 
Figure 9. Effect of time of bFGF addition on percentage of HGF/SF-treated ROSE cells undergoing apoptosis. In this study ROSE cells were treated with HGF/SF. bFGF was added at 0, 2, and 4 h after HGF/SF. After 24 h of culture, apoptotic cells were identified by presence of apoptotic nuclei. *, Indicates that a value is significantly different from 0- and 2-h values (P < 0.05).

 
Like HGF/SF, both Thap and Bay K induced a 2- to 3-fold increase in [Ca2+]i levels at 4 h of culture (Fig. 10Go) and increased ROSE cell apoptosis by 24 h of culture (Fig. 11Go). Unlike HGF/SF, Thap and Bay K mediated their apoptotic action in the presence of either Act D or CHX (Figs. 2Go and 12Go). bFGF attenuated both Thap- and Bay K-induced increase in [Ca2+]i levels (Fig. 10Go) and apoptosis (Fig. 11Go). Further, bFGF inhibited Bay K-induced apoptosis in the presence of Act D (Fig. 12Go).



View larger version (35K):
[in this window]
[in a new window]
 
Figure 10. Effect of Thap (A), Bay K (B), and bFGF on ROSE cell [Ca2+]i levels. *, Indicates that a value is significantly different from all other values (P < 0.05).

 


View larger version (29K):
[in this window]
[in a new window]
 
Figure 11. Effect of Thap (A), Bay K (B), and bFGF on percentage of ROSE cells undergoing apoptosis. *, Indicates that a value is significantly different from all other values (P < 0.05).

 


View larger version (60K):
[in this window]
[in a new window]
 
Figure 12. Effect of bFGF and Bay K in presence of Act D on percentage of ROSE cells undergoing apoptosis. **, Indicates that a value is significantly greater than all other groups (P < 0.05). *, Indicates that a value is significantly less than control value (P < 0.05).

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
HGF/SF is a pluripotent growth factor that can promote 1) cell dissociation with the loss of adhesion and junctional communication; 2) cell migration; and/or 3) mitosis, depending on the cell type and culture conditions (7, 8). The present study demonstrates that HGF/SF decreases cell contact between ROSE cells but does not influence the rate of mitosis. In ROSE cells, N-cadherin-mediated cell contact stimulates a tyrosine phosphorylation pathway that ultimately maintains their viability (4). It is likely that HGF/SF’s ability to reduce cell contact between ROSE cells accounts in part for its apoptotic action.

The cascade of cellular and molecular events that induce cells to become apoptotic is poorly defined (17). It has been proposed that once a cell reaches a point in the apoptotic cascade, it is committed to die (18). Although an increase in [Ca2+]i is not always observed during apoptosis (14, 18), an increase in [Ca2+]i is observed 3 h post HGF/SF and is sustained for at least 1 h. This sustained increase in [Ca2+]i appears to demark the commitment point for ROSE cells, because BAPTA prevents both the HGF/SF-induced increase in [Ca2+]i levels and apoptosis. This concept is further supported by the following observations. First, bFGF attenuates HGF/SF’s ability to induce both [Ca2+]i and apoptosis. Second, bFGF cannot attenuate HGF/SF’s apoptotic action if exposed to cells after the increase in [Ca2+]i (i.e. 4 h after HGF/SF). Third, Act D and CHX block HGF/SF’s ability to induce an increase in [Ca2+]i and apoptosis. Note that Bay K induces an increase in [Ca2+]i and apoptosis even in the presence of Act D. This indicates that Act D per se does not prevent the ROSE cells from responding to HGF/SF with an increase in [Ca2+]i. Rather it supports the concept that de novo RNA and protein synthesis are required for HGF/SF to increase [Ca2+]i. Finally, Thap and Bay K, agents that increase [Ca2+]i, induce apoptosis in an RNA/protein synthesis-independent manner. This demonstrates that the components of the apoptotic cascade distal to the increase in [Ca2+]i are present within ROSE cells. This is consistent with the concept that calcium-dependent proteases and endonucleases are already present within the cells, and that all that is necessary to induce apoptosis is for these enzymes to be activated by an increase in [Ca2+]i (19, 20. Because [Ca2+]i plays an essential role in initiating apoptosis, attention needs to be focused on how HGF/SF promotes a sustained elevation in [Ca2+]i levels.

HGF/SF decreases cell contact before the increase in [Ca2+]i levels. This temporal relationship suggests that a decrease in cell contact leads to an increase in [Ca2+]i. This hypothesis is supported by three sets of observations. First, ROSE cells that form a cell-cell contact have [Ca2+]i levels that are one-third those of single ROSE cells. Second, ROSE cells that contact N-cadherin-expressing 3T3 cells possess [Ca2+]i levels that are one-third those of ROSE cells that contact control vector 3T3 cells. Finally, a synthetic N-cadherin peptide allows ROSE cells to establish cell contact with each other, but attentuates the ability of cell contact to maintain low basal [Ca2+]i levels. Collectively, these studies demonstrate that homophilic N-cadherin binding between adjacent cells maintains calcium homeostasis. Similarly, N-cadherin plays an essential role in maintaining low basal levels of [Ca2+]i in glial cells (21). In nonovarian cells, HGF/SF decreases cadherin levels (22) and/or stimulates the tyrosine phosphorylation of catenins (23), with the end result being a loss of cell contact (24). Either or both of these actions could be responsible for HGF/SF’s ability to promote the disaggregation of ROSE cells and therefore, explain the HGF/SF-induced increase in [Ca2+]i levels.

Although the loss of cell contact between ROSE cells undoubtedly accounts in part for the increase in [Ca2+]i, HGF/SF may have additional actions that lead to the disregulation of [Ca2+]i and ultimately to cell death. Ovarian surface epithelial cells express c-met, the receptor for HGF/SF (11). Ligand activation of c-met results in its autotyrosine phosphorylation and subsequent increase in inositol 1,4,5-triphosphate (IP3) (7, 8). In hepatocytes, intracellular levels of IP3 are elevated within minutes of exposure to HGF/SF and remain elevated for up to 5 h (25). IP3 binds to IP3 receptors promoting the release of calcium from its stores (26). This results in an immediate increase in [Ca2+]i that is generally transient, lasting only a few minutes, and that is associated with mitosis (25). HGF/SF also stimulates an increase in [Ca2+]i in ROSE cells but does not induce mitosis. Rather, HGF/SF promotes ROSE cell apoptosis. Because the present studies were not designed to detect transient changes in [Ca2+]i as observed in response to mitogenic stimuli, it is possible that brief calcium transients occur immediately after HGF/SF. The present studies do detect major changes in [Ca2+]i that are associated with ROSE cell apoptosis. These changes differ from those associated with mitosis in that they 1) are delayed, increasing 2- to 3- fold over control values by 3 h of HGF/SF treatment; 2) are prolonged, lasting at least 1 h; and 3) require de novo RNA and protein synthesis. The identity of newly synthesized proteins that may act in concert with IP3 to increase [Ca2+]i are unknown. Recently, the expression of type 3 IP3 receptors has been shown to be induced during glucocorticoid-stimulated apoptosis of lymphocytes (24). Activation of the type 3 IP3 receptor results in a prolonged 4-fold increase in [Ca2+]i (24). It is possible then that type 3 IP3 receptors are one of several HGF/SF-induced proteins that deregulate [Ca2+]i. This hypothesis is currently being tested.

The present data also demonstrate that in ROSE cells bFGF is not mitogenic but rather functions as a survival factor. In other cells, protein kinase C activation mediates bFGF’s antiapoptotic action (27, 28). Ovarian epithelial cells express FGF receptors (29), and ligand binding to the FGF receptors stimulates a signal transduction pathway that leads to the generation of IP3 and the activation of protein kinase C (30). One consequence of protein kinase C activation is to stimulate the uptake of calcium into its cellular stores (26, 31). This counteracts the IP3-induced increase in [Ca2+]i, thereby maintaining calcium homeostasis. The present studies show that bFGF mediates its antiapoptotic action by blocking HGF/SF-, Thap-, and Bay K-induced increase in [Ca2+]i. Similarly, bFGF has been shown to prevent neuronal apoptosis by stabilizing calcium homeostasis (32). Based on these findings, it is possible that stimulation of protein kinase C activity could account for bFGF’s ability to block the sustained increase in [Ca2+]i levels, thus preventing ROSE cell apoptosis. This concept is consistent with the observation that the ability of bFGF to regulate [Ca2+]i and apoptosis is not dependent on de novo RNA and protein synthesis.

Finally, these in vitro studies suggest that the apoptotic action of HGF/SF could play an important role in the ovulatory process. For example, as preovulatory follicles develop, they secrete estrogen with maximum estrogen levels being obtained just before ovulation (33). Because estrogen increases the expression of HGF/SF (11), it is likely that ovarian HGF/SF levels are at their maximum at this time. Estrogen also induces an LH surge that initiates an array of physiological events that ultimately result in ovulation. One of these ovulatory events is the breakdown of the basement membrane of the ovulatory follicle (34). This would expose the surface epithelial cells to stromal/thecal cell-derived HGF/SF. HGF/SF could then stimulate the surface epithelial cells to undergo apoptosis. This hypothesis is consistent with the observed apoptosis of the surface epithelial cell layer that overlies the ovulatory follicles (2, 3). This apoptotic event is an important part of the ovulation cascade because it creates an opening through which the oocyte is released. Further, failure of the surface epithelial cells to undergo apoptosis would entrap the oocyte and potentially result in a luteinized unruptured follicle.


    Acknowledgments
 
We are grateful to Dr. Bruce A. White for his thoughtful advice throughout the course of this study and to Ms. Anna Pappalardo for her excellent technical assistance. We also thank Dr. Robert Burghardt of Texas A & M University for providing the ROSE cells, Dr. Ralph Schwall of Genentech Inc. for the HGF/SF, and Dr. Patrick Doherty of the Guy’s Hospital-University of London for the parental and N-cadherin-expressing 3T3 cells.

Received October 10, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Hsueh A, Billig H, Tsafriri A 1994 Ovarian follicle atresia: a hormonally controlled apoptotic process. Endocr Rev 15:707–724[CrossRef][Medline]
  2. Ackerman RC, Murdoch WJ 1993 Prostaglandin-induced apoptosis of ovarian surface epithelial cells. Prostaglandins 45:475–485[CrossRef][Medline]
  3. Murdoch WJ 1995 Programmed cell death in preovulatory ovine follicles. Biol Reprod 53:8–12[Abstract]
  4. Trolice MP, Pappalardo A, Peluso JJ 1997 Basic fibroblast growth factor and N-cadherin maintain rat granulosa cell and ovarian surface epithelial cell viability by stimulating the tyrosine phosphorylation of the fibroblast growth factor receptors. Endocrinology 138:107–113[Abstract/Free Full Text]
  5. Peluso J, Pappalardo A, Trolice M 1996 N-cadherin-mediated cell contact inhibits granulosa cell apoptosis in a progesterone-independent manner. Endocrinology 137:1196–1203[Abstract]
  6. Tilly JL, Billig H, Kowalski KI, Hsueh A 1992 Epidermal growth factor and basic fibroblast growth factor suppress the spontaneous onset of apoptosis in cultured rat ovarian granulosa cells and follicles by a tyrosine kinase-dependent mechanism. Mol Endocrinol 6:1942–1950[Abstract]
  7. Furlong RA 1992 The biology of hepatocyte growth factor/scatter factor. BioEssays 14:613–617[CrossRef][Medline]
  8. Rubin JS, Bottaro DP, Aaronson SA 1993 Heptocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta 1155:357–371[Medline]
  9. Parrott JA, Vigne JL, Chu BZ, Skinner MK 1994 Mesenchymal-epithelial interactions in the ovarian follicle involve keratinocyte and hepatocyte growth factor production by thecal cells and their action on granulosa cells. Endocrinology 135:569–575[Abstract]
  10. Liu Y, Lin L, Zarnegar R 1994 Modulation of hepatocyte growth factor gene expression by estrogen in mouse ovary. Mol Cell Endocrinol 104:173–181[CrossRef][Medline]
  11. Moghul A, Lin L, Beedle A, Kanbour-Shakir A, DeFrances MC, Liu Y, Zarnegar R 1994 Modulation of c-met proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-met transcript. Oncogene 9:2045–2052[Medline]
  12. Di Renzo MF, Olivero M, Katsaros D, Crepaldi T, Gaglia P, Zola P, Sismondi P, Comoglio PM 1994 Overexpression of the met/HGF receptor in ovarian cancer. Int J Cancer 58:658–662[Medline]
  13. Hoffman AG, Burghardt RC, Tilley R, Auersperg N 1993 An in vitro model of ovarian epithelial carcinogenesis: changes in cell-cell communication and adhesion occurring during neoplastic progression. Int J Cancer 54:828–838[Medline]
  14. Orrenius S, Nicotera P 1994 The calcium ion and cell death. J Neural Transm Suppl 43:1–11[Medline]
  15. Luciano AM, Pappalardo A, Ray C, Peluso JJ 1994 Epidermal growth factor inhibits large granulosa cell apoptosis by stimulating progesterone synthesis and regulating the distribution of intracellular free calcium. Biol Reprod 51:646–654[Abstract]
  16. Williams EJ, Furness J, Walsh FS, Doherty P 1994 Activation of the FGF receptor underlies neurite outgrowth stimulated by L1, N-CAM and N-cadherin. Neuron 13:583–594[CrossRef][Medline]
  17. Steller H 1995 Mechanisms and genes of cellular suicide. Science 267:1445–1462[Abstract/Free Full Text]
  18. Kroemer G, Petit P, Zamzami N, Vayssiere J-L, Mignotte B 1995 The biochemistry of programmed cell death. FASEB J 9:1277–1287[Abstract]
  19. Martin S, Green DR 1995 Protease activation during apoptosis: death by a thousand cuts. Cell 82:349–352[CrossRef][Medline]
  20. Patel T, Gores GJ, Kaufmann SH 1996 The role of proteases during apoptosis. FASEB J 10:587–597[Abstract]
  21. Bixby JL, Grunwald GB, Bookman RJ 1994 Ca2+ influx and neurite growth in response to purified N-cadherin and laminin. J Cell Biol 127:1461–1475[Abstract/Free Full Text]
  22. Tannapfel A, Yasui W, Yokozaki H, Wittekind C, Tahara E 1994 Effect of hepatocyte growth factor on the expression of E- and P-cadherin in gastric carcinoma cell lines. 425:139–144
  23. Shibamoto S, Hayakawa M, Takeuchi K, Hori T, OKi N, Miyazawa K, Kitamura N, Takeichi M, Ito F 1994 Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhes Commun 1:295–305[Medline]
  24. Khan AA, Soloski MJ, Sharp AH, Schilling G, Sabatini DM, Li S-H, Ross CA, Snyder SH 1996 Lymphocyte apoptosis: mediation by increased type 3 inositol 1,4,5-trisphosphate receptor. Science 273:503–507[Abstract]
  25. Baffy G, Yang L, Michalopoulos GK, Williamson JR 1992 Hepatocyte growth factor induces calcium mobilization and inositol phosphate production in rat hepatocytes. J Cell Physiol 153:332–339[CrossRef][Medline]
  26. Fewtrell C 1993 Ca2+ oscillations in non-excitable cells. Annu Rev Physiol 55:427–454[CrossRef][Medline]
  27. Haimovitz-Friedman A, Balaban N, McLoughlin M, Ehleiter D, Michaeli J, Vlodavsky I, Fuks Z 1994 Protein kinase C mediates basic fibroblast growth factor protection of endothelial cells against radiation-inducted apoptosis. Cancer Res 54:2591–2597[Abstract/Free Full Text]
  28. Hase M, Araki S, Kaji K, Hayashi H 1994 Classification of signals for blocking apoptosis in vascular endothelial cells. J Biochem 116:905–909[Abstract/Free Full Text]
  29. Asakai R, Song S-Y, Itoh N, Yamakuni T, Tamura K, Okamoto R 1994 Differential gene expression of fibroblast growth factor receptor isoforms in rat ovary. Mol Cell Endocrinol 104:75–80[CrossRef][Medline]
  30. Jaye M, Schlessinger J, Dionne CA 1992 Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135:185–199[Medline]
  31. Fay FS, Gilbert SH, Brundage RA 1995 Calcium signalling during chemotaxis. Ciba Found Symp 188:121–135[Medline]
  32. Mattson MP, Cheng B 1993 Growth factors protect neurons against excitotoxic/ischemic damage by stabilizing calcium homeostasis. Stroke 24:I136–I140
  33. Greenwald G, Terranova P 1988 Follicular selection and its control. In: Knobil E, Neil JD (eds) The Physiology of Reproduction. Raven Press, New York, pp 387–446
  34. Tsafriri A 1995 Ovulation as a tissue remodelling process. Proteolysis and cumulus expansion. Adv Exp Med Biol 377:121–140[Medline]



This article has been cited by other articles:


Home page
J Mol EndocrinolHome page
N. Gava, C. L. Clarke, C. Bye, K. Byth, and A. deFazio
Global gene expression profiles of ovarian surface epithelial cells in vivo
J. Mol. Endocrinol., June 1, 2008; 40(6): 281 - 296.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. J. Peluso, X. Liu, and J. Romak
Progesterone Maintains Basal Intracellular Adenosine Triphosphate Levels and Viability of Spontaneously Immortalized Granulosa Cells by Promoting an Interaction between 14-3-3{sigma} and ATP Synthase{beta}/Precursor through a Protein Kinase G-Dependent Mechanism
Endocrinology, May 1, 2007; 148(5): 2037 - 2044.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Rasola, S. Anguissola, N. Ferrero, D. Gramaglia, A. Maffe, P. Maggiora, P. M. Comoglio, and M. F. Di Renzo
Hepatocyte Growth Factor Sensitizes Human Ovarian Carcinoma Cell Lines to Paclitaxel and Cisplatin
Cancer Res., March 1, 2004; 64(5): 1744 - 1750.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. Auersperg, A. S. T. Wong, K.-C. Choi, S. K. Kang, and P. C. K. Leung
Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology
Endocr. Rev., April 1, 2001; 22(2): 255 - 288.
[Abstract] [Full Text]


Home page
Ann. N. Y. Acad. Sci.Home page
S. MUSSCHE, L. LEYBAERT, and K. D'HERDE
First and Second Messenger Role of Calcium: Survival versus Apoptosis in Serum-Free Cultured Granulosa Explants
Ann. N.Y. Acad. Sci., December 1, 2000; 926(1): 101 - 115.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L. M. Senturk, E. Seli, L. S. Gutierrez, G. Mor, H. B. Zeyneloglu, and A. Arici
Monocyte chemotactic protein-1 expression in human corpus luteum
Mol. Hum. Reprod., August 1, 1999; 5(8): 697 - 702.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
Y. Osuga, O. Tsutsumi, M. Momoeda, R. Okagaki, H. Matsumi, H. Hiroi, A. Suenaga, T. Yano, and Y. Taketani
Evidence for the presence of hepatocyte growth factor expression in human ovarian follicles
Mol. Hum. Reprod., August 1, 1999; 5(8): 703 - 707.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
D. W. Powell, R. C. Mifflin, J. D. Valentich, S. E. Crowe, J. I. Saada, and A. B. West
Myofibroblasts. I. Paracrine cells important in health and disease
Am J Physiol Cell Physiol, July 1, 1999; 277(1): C1 - C19.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Hess, R. Gulati, and J. J. Peluso
Hepatocyte Growth Factor Induces Rat Ovarian Surface Epithelial Cell Mitosis or Apoptosis Depending on the Presence or Absence of an Extracellular Matrix
Endocrinology, June 1, 1999; 140(6): 2908 - 2916.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
D. M. Nash, S. A. Hess, B. A. White, and J. J. Peluso
Steroidogenic Factor-1 Regulates the Rate of Proliferation of Normal and Neoplastic Rat Ovarian Surface Epithelial Cells in Vitro
Endocrinology, November 1, 1998; 139(11): 4663 - 4671.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
M. Lail-Trecker, R. Gulati, and J. J. Peluso
A Role for Hepatocyte Growth Factors/Scatter Factor in Regulating Normal and Neoplastic Cells of Reproductive Tissues
Reproductive Sciences, May 1, 1998; 5(3): 114 - 121.
[Abstract] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gulati, R.
Right arrow Articles by Peluso, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gulati, R.
Right arrow Articles by Peluso, J. J.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS